Description
SWOT ANALYSIS OF FOREST LABORATORIES
Forest laboratories
Parent Company
Forest laboratories
Category
Pharmaceuticals
Sector
Healthcare
Tagline/ Slogan
Guided by principles, powered by people
USP
It is ranked third in top companies to sell for survey
STP
Segment
Central nervous system & cardiovascular diseases
Healthcare professionals offering solutions is CNS & cardiovascular Target Group diseases
Forest identifies, develops and delivers pharmaceutical products that Positioning make difference in people’s lives.
SWOT Analysis
1. They have many blockbuster drugs such as Lexpro, Namenda, Bystolic. 2. Approval of Daliresp which is novel, first of ts kind drug in chronic Obstructive Pulmonary disease 3. They have 5600 well trained employees 4. Strong product pipeline Strength 5. Strong brand name in the pharmaceutical industry
1. Strong competition form other brands means the growth scope is limited Weakness 2. It receives majority of its revenue from only four drugs
1. Increasing awareness about healthcare 2. Increasing awareness about medical insurance Opportunity 3. Increasing global ageing population
1. Forest operates in anti depressant market which has become Threats crowded with many products and has shown signs of slowdown
2. More stringent drug development guidelines 3. Economic slowdown
Competition
1. Teva pharmaceuticals 2. Pfizer 3. Eli Lilly Competitors 4. AstraZeneca
doc_292652243.docx
SWOT ANALYSIS OF FOREST LABORATORIES
Forest laboratories
Parent Company
Forest laboratories
Category
Pharmaceuticals
Sector
Healthcare
Tagline/ Slogan
Guided by principles, powered by people
USP
It is ranked third in top companies to sell for survey
STP
Segment
Central nervous system & cardiovascular diseases
Healthcare professionals offering solutions is CNS & cardiovascular Target Group diseases
Forest identifies, develops and delivers pharmaceutical products that Positioning make difference in people’s lives.
SWOT Analysis
1. They have many blockbuster drugs such as Lexpro, Namenda, Bystolic. 2. Approval of Daliresp which is novel, first of ts kind drug in chronic Obstructive Pulmonary disease 3. They have 5600 well trained employees 4. Strong product pipeline Strength 5. Strong brand name in the pharmaceutical industry
1. Strong competition form other brands means the growth scope is limited Weakness 2. It receives majority of its revenue from only four drugs
1. Increasing awareness about healthcare 2. Increasing awareness about medical insurance Opportunity 3. Increasing global ageing population
1. Forest operates in anti depressant market which has become Threats crowded with many products and has shown signs of slowdown
2. More stringent drug development guidelines 3. Economic slowdown
Competition
1. Teva pharmaceuticals 2. Pfizer 3. Eli Lilly Competitors 4. AstraZeneca
doc_292652243.docx